Favorites: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
<table border="0"><tr><td> | <table border="0"><tr><td> | ||
* [[Tutorial:How_do_we_get_the_oxygen_we_breathe]] | * [[Tutorial:How_do_we_get_the_oxygen_we_breathe]] | ||
* [[Tutorial:Ramachandran principle and phi psi angles]] | |||
* [[SARS-CoV-2 spike protein fusion transformation]] | * [[SARS-CoV-2 spike protein fusion transformation]] | ||
* [[SARS-CoV-2_protein_S_priming_by_furin]] | * [[SARS-CoV-2_protein_S_priming_by_furin]] | ||
Line 14: | Line 15: | ||
* [[Angiotensin-Converting Enzyme]] | * [[Angiotensin-Converting Enzyme]] | ||
* [[Triose Phosphate Isomerase]] | * [[Triose Phosphate Isomerase]] | ||
</td><td> | </td><td> | ||
| | ||
Line 21: | Line 22: | ||
* [[DNA]] | * [[DNA]] | ||
* [[TRNA]] | * [[TRNA]] | ||
* [[Pharmaceutical_Drugs]] | * [[Pharmaceutical_Drugs]] | ||
* [[Resolution]] | * [[Resolution]] | ||
Line 31: | Line 31: | ||
* [[Vascular Endothelial Growth Factor|VEGF]] & [[Vascular Endothelial Growth Factor Receptor|VEGFR]] | * [[Vascular Endothelial Growth Factor|VEGF]] & [[Vascular Endothelial Growth Factor Receptor|VEGFR]] | ||
* [[HMG-CoA Reductase]] | * [[HMG-CoA Reductase]] | ||
* [[Proteopedia:Video_Guide]] | |||
* See also: [[Personal_favorites | Personal favorites pages]] and [[Special:Popularpages | Popular pages]] | * See also: [[Personal_favorites | Personal favorites pages]] and [[Special:Popularpages | Popular pages]] | ||
</td></tr></table> | </td></tr></table> | ||
==Personal Favorites Lists== | ==Personal Favorites Lists== | ||
[[Personal favorites]] includes lists of favorites made by specific users. | [[Personal favorites]] includes lists of favorites made by specific users. |
Revision as of 23:12, 10 November 2021
Here are several of our users' favorite pages. Visit them to get a feeling for Proteopedia, and add your own favorites:
Personal Favorites ListsPersonal Favorites Lists
Personal favorites includes lists of favorites made by specific users.